A new minimally invasive procedure, genicular artery embolization (GAE), shows promise in reducing osteoarthritis knee pain and may help patients avoid knee replacement surgery.
A new oral GLP-1 drug, aleniglipron, showed significant weight loss of up to 12.1% in a 36-week trial, offering a potential alternative to injectable medications.
A major study involving nearly 4,000 infants found acetaminophen and ibuprofen safe, with no increased risk of eczema or bronchiolitis in the first year.
A major U.S. clinical trial found that silver diamine fluoride liquid can stop decay in over half of treated baby teeth, offering a drill-free alternative for childhood cavities.
A clinical trial found that a daily prebiotic fiber supplement reduced knee osteoarthritis pain, improved grip strength, and decreased pain sensitivity, suggesting a gut-muscle-pain connection.
A study found that a 12-week intermittent fasting program helped overweight and obese adults sustain weight loss for at least one year after the intervention.
A traditional Chinese medicinal root, Polygonum multiflorum, is showing potential as a multi-faceted treatment for androgenetic alopecia, according to a new scientific review.
A clinical trial found that a personalized adjustment to walking gait can significantly reduce knee osteoarthritis pain and slow cartilage damage, offering a non-pharmacological treatment option.
A clinical trial found that personalized gait retraining, involving a small change in foot angle while walking, reduced knee osteoarthritis pain and slowed cartilage degradation.
A large European study found that a modified Mediterranean diet, combined with exercise and weight loss support, reduced the risk of type two diabetes by 31 percent.
CAR T-cell therapy, a cancer treatment, is being explored for autoimmune diseases like multiple sclerosis, aiming to reset the immune system by targeting specific cells.
An 800-year-old Chinese exercise, Baduanjin, was found to lower blood pressure as effectively as medication in a large clinical trial, with benefits lasting a year.
A clinical trial found that the common constipation drug lubiprostone may slow the progression of chronic kidney disease by altering gut bacteria and improving mitochondrial function.
A clinical trial found that nine weeks of immunotherapy before surgery kept specific colorectal cancer patients cancer-free for nearly three years.